These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
150 related items for PubMed ID: 12185442
1. The -260 C-->T promoter polymorphism of the lipopolysaccharide receptor CD14 and severe sepsis in trauma patients. Heesen M, Bloemeke B, Schade U, Obertacke U, Majetschak M. Intensive Care Med; 2002 Aug; 28(8):1161-3. PubMed ID: 12185442 [Abstract] [Full Text] [Related]
3. Lack of association between the -260 C-->T promoter polymorphism of the endotoxin receptor CD14 gene and the CD14 density of unstimulated human monocytes and soluble CD14 plasma levels. Heesen M, Blömeke B, Schlüter B, Heussen N, Rossaint R, Kunz D. Intensive Care Med; 2001 Nov; 27(11):1770-5. PubMed ID: 11810121 [Abstract] [Full Text] [Related]
5. CD14 expression on monocytes and soluble CD14 plasma levels in correlation to the promotor polymorphism of the endotoxin receptor CD14 gene in patients with inactive Crohn's disease. Griga T, Klein W, Epplen JT, Hebler U, Stachon A, May B. Hepatogastroenterology; 2005 Nov; 52(63):808-11. PubMed ID: 15966209 [Abstract] [Full Text] [Related]
6. CD14 gene polymorphism 159C/T in a group of patients with coronary artery disease from a population with high morbidity of cardiovascular diseases. Rechciński T, Grebowska A, Kurpesa M, Peruga Z, Dziuba M, Krzemińska-Pakuła M, Rudnicka W, Chmiela M. Kardiol Pol; 2007 Mar; 65(3):237-44; discussion 245. PubMed ID: 17436151 [Abstract] [Full Text] [Related]
7. Promoter polymorphism of the CD14 endotoxin receptor gene as a risk factor for alcoholic liver disease. Järveläinen HA, Orpana A, Perola M, Savolainen VT, Karhunen PJ, Lindros KO. Hepatology; 2001 May; 33(5):1148-53. PubMed ID: 11343243 [Abstract] [Full Text] [Related]
13. The interleukin-6 G(-174)C polymorphism and the ex vivo interleukin-6 response to endotoxin in severely injured blunt trauma patients. Heesen M, Obertacke U, Schade FU, Bloemeke B, Majetschak M. Eur Cytokine Netw; 2002 May; 13(1):72-7. PubMed ID: 11956023 [Abstract] [Full Text] [Related]
14. Influence of the CD14 C260T promoter polymorphism on C-reactive protein levels in patients with coronary artery disease. Bernardo E, Angiolillo DJ, Ramírez C, Cavallari U, Trabetti E, Sabaté M, Hernández R, Moreno R, Escaned J, Alfonso F, Bañuelos C, Costa MA, Bass TA, Pignatti PF, Macaya C, Fernandez-Ortiz A. Am J Cardiol; 2006 Nov 01; 98(9):1182-4. PubMed ID: 17056323 [Abstract] [Full Text] [Related]
15. A polymorphism in the promoter of the CD14 gene (CD14/-159) is associated with the development of coronary artery lesions in patients with Kawasaki disease. Nishimura S, Zaitsu M, Hara M, Yokota G, Watanabe M, Ueda Y, Imayoshi M, Ishii E, Tasaki H, Hamasaki Y. J Pediatr; 2003 Sep 01; 143(3):357-62. PubMed ID: 14517520 [Abstract] [Full Text] [Related]
16. Association of CD14 promoter gene polymorphism and Chlamydia pneumoniae infection. Eng HL, Chen CH, Kuo CC, Wu JS, Wang CH, Lin TM. J Infect Dis; 2003 Jul 01; 188(1):90-7. PubMed ID: 12825176 [Abstract] [Full Text] [Related]
17. Single-nucleotide polymorphisms in the Toll-like receptor pathway increase susceptibility to infections in severely injured trauma patients. Bronkhorst MW, Boyé ND, Lomax MA, Vossen RH, Bakker J, Patka P, Van Lieshout EM. J Trauma Acute Care Surg; 2013 Mar 01; 74(3):862-70. PubMed ID: 23425749 [Abstract] [Full Text] [Related]
18. CD14 C(-260)T promoter polymorphism and prevalence of acute coronary syndromes. Arroyo-Espliguero R, El-Sharnouby K, Vázquez-Rey E, Kalidas K, Jeffery S, Kaski JC. Int J Cardiol; 2005 Feb 15; 98(2):307-12. PubMed ID: 15686783 [Abstract] [Full Text] [Related]